Search Results - Ian Proctor
- Showing 1 - 4 results of 4
-
1
Bortezomib‐based therapy is effective and well tolerated in frontline and multiply pre‐treated Waldenström macroglobulinaemia including BTKi failures: A real‐world analysis by Jahanzaib Khwaja, Encarl Uppal, Robert Baker, Kajal Trivedi, Ali Rismani, Rajeev Gupta, Ian Proctor, Charalampia Kyriakou, Shirley D'Sa
Published in eJHaem (2022-11-01)Get full text
Article -
2
Biallelic deleterious germline SH2B3 variants cause a novel syndrome of myeloproliferation and multi‐organ autoimmunity by Piers Blombery, Vahid Pazhakh, Adriana S. Albuquerque, Jesmeen Maimaris, Lingge Tu, Brenda Briones Miranda, Florence Evans, Ella R. Thompson, Ben Carpenter, Ian Proctor, Julie A. Curtin, Jonathan Lambert, Siobhan O. Burns, Graham J. Lieschke
Published in eJHaem (2023-05-01)Get full text
Article -
3
Dissecting CD47 expression in lymphoid neoplasms to inform precision immunotherapy with anti-CD47 phagocytic checkpoint blockade by Andrea Marra, Alan Ramsay, Samuel Chamberlain-Keene, Gabriela Soares, Maurilio Ponzoni, Sugerdana Padmasri, Manuel Rodriguez-Justo, Sabine Pomplun, Ian Proctor, Anna Childerhouse, Alsharabati Muntasser, Mario Cioce, Vito Michele Fazio, German Ott, Miguel Piris, Brunangelo Falini, Teresa Marafioti
Published in Haematologica (2025-03-01)Get full text
Article -
4
CD47 expression in acute myeloid leukemia varies according to genotype by Andrea Marra, Ayse U Akarca, Giovanni Martino, Alan Ramsay, Stefano Ascani, Vincenzo Maria Perriello, Jenny O’Nions, Andrew J Wilson, Rajeev Gupta, Anna Childerhouse, Ian Proctor, Manuel Rodriguez-Justo, Sabine Pomplun, Maria Paola Martelli, Cristina Lo Celso, Brunangelo Falini, Teresa Marafioti
Published in Haematologica (2023-06-01)Get full text
Article
